Rachel Koster
Physician Assistant · Spring, TXNPI 1437469830
Payments from drug & device makers
Across 93 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$303
- AstraZeneca$269
- Lilly USA, LLC$260
- Novartis$182
- Pfizer$152
- Novo Nordisk$132
- plus $521 from 13 others
What the payments were for
- Food & beverage$1,810100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 16 | $303 |
| AstraZeneca | 12 | $269 |
| Lilly USA, LLC | 15 | $260 |
| Novartis | 8 | $182 |
| Pfizer | 7 | $152 |
| Novo Nordisk | 8 | $132 |
| GSK | 6 | $113 |
| Astellas Pharma US Inc | 4 | $83 |
| Boehringer Ingelheim | 3 | $70 |
| Amgen | 4 | $61 |
| Exact Sciences | 2 | $38 |
| Fresenius Kabi USA, LLC | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Fennec Pharmaceuticals, Inc. | 1 | $23 |
| Seqirus USA Inc | 1 | $22 |
| Corcept Therapeutics | 1 | $20 |
| Medtronic | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$1,818 in reported general payments places this provider in the 75th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 57 | $104,838 |
| RybelsusSemaglutide | 34 | $74,051 |
| MounjaroTirzepatide | 59 | $71,969 |
| FarxigaDapagliflozin Propanediol | 62 | $70,377 |
| GemtesaVibegron | 45 | $49,555 |
| JardianceEmpagliflozin | 45 | $47,012 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $35,607 |
| TrulicityDulaglutide | 23 | $28,923 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 22 | $25,705 |
| JanuviaSitagliptin Phosphate | 19 | $23,461 |
| EliquisApixaban | 20 | $21,181 |
| MyrbetriqMirabegron | 17 | $19,178 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $13,684 |
| XareltoRivaroxaban | 11 | $12,919 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 36 | $11,499 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $132 | $178,88991 claims |
| Lilly USA, LLCMounjaro, Trulicity | $260 | $100,89282 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $269 | $84,06173 claims |
| GSKTrelegy Ellipta, Arexvy, Shingrix | $113 | $54,00089 claims |
| Boehringer IngelheimJardiance, Synjardy | $70 | $52,26056 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $24 | $49,55545 claims |
| PfizerEliquis, Paxlovid | $152 | $22,61031 claims |
| Astellas Pharma US IncMyrbetriq | $83 | $19,17817 claims |
| AbbVieSynthroid | $303 | $4,95769 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Spring
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.